Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
Supporting Files
Public Domain
-
December 07 2014
-
File Language:
English
Details
-
Alternative Title:Infect Dis Obstet Gynecol
-
Personal Author:
-
Description:To describe the antiviral treatment patterns for chronic hepatitis B (CHB) among pregnant and nonpregnant women.|Using 2011 MarketScan claims, we calculated the rates of antiviral treatment among women (aged 10-50 years) with CHB. We described the pattern of antiviral treatment during pregnancy and ≥1 month after delivery.|We identified 6274 women with CHB during 2011. Among these, 64 of 507 (12.6%) pregnant women and 1151 of 5767 (20.0%) nonpregnant women received antiviral treatment (P < 0.01). Pregnant women were most commonly prescribed tenofovir (73.4%) and lamivudine (21.9%); nonpregnant women were most commonly prescribed tenofovir (50.2%) and entecavir (41.3%) (P < 0.01). Among 48 treated pregnant women with an identifiable delivery date, 16 (33.3%) were prescribed an antiviral before pregnancy and continued treatment for at least one month after delivery; 14 (29.2%) started treatment during the third trimester and continued at least one month after delivery.|Among this insured population, pregnant women with CHB received an antiviral significantly less often than nonpregnant women. The most common antiviral prescribed for pregnant women was tenofovir. These data provide a baseline for assessing changes in treatment patterns with anticipated increased use of antivirals to prevent breakthrough perinatal hepatitis B virus infection.
-
Subjects:
-
Source:Infect Dis Obstet Gynecol. 2014; 2014
-
Pubmed ID:25548510
-
Pubmed Central ID:PMC4274824
-
Document Type:
-
Place as Subject:
-
Volume:2014
-
Collection(s):
-
Main Document Checksum:urn:sha256:271bfcf6455482b2c7ed4b79603910e8cf9b06de3284aff04bd9d33d1cd44ac6
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access